American Friends of Bar-Ilan University
  • HOME
  • ABOUT US
    •  
      • AMERICAN FRIENDS OF BAR-ILAN UNIVERSITY
      • BAR-ILAN UNIVERSITY NEWS
      • 2025 PRESIDENT’S REPORT
      • Browse past reports
      • 2024 PRESIDENT’S REPORT
      • 2023 PRESIDENT’S REPORT
      • 2022 PRESIDENT’S REPORT
      • 2021 PRESIDENT’S REPORT
  • SCIENCE & TECHNOLOGY
    •  
      • LIFE SCIENCES
      • COMPUTER SCIENCE & CYBERSECURITY
      • NANOTECHNOLOGY
      • ROBOTICS & ENGINEERING
      • SUSTAINABLE ENERGY
  • JEWISH STUDIES
      •  
      • JEWISH STUDIES – Communicating the relevance of Jewish Studies and Jewish values.
      • THE LOOKSTEIN CENTER FOR JEWISH EDUCATION
      • MIDRASHA INSTITUTE FOR WOMEN
      • LUDWIG AND ERICA JESSELSON INSTITUTE
        FOR ADVANCED TORAH STUDY
    •  
      • JEWISH STUDIES – Communicating the relevance of Jewish Studies and Jewish values.
      • THE LOOKSTEIN CENTER FOR JEWISH EDUCATION
      • MIDRASHA INSTITUTE FOR WOMEN
      • LUDWIG AND ERIKA JESSELSON INSTITUTE
        FOR ADVANCED TORAH STUDY
      • BIBLICAL ARCHAEOLOGY
      • Tel Zafit Archaeological Site
  • MEDICINE
    •  
      • AZRIELI FACULTY OF MEDICINE
        IN THE GALILEE
        – Bar-Ilan’s School of Medicine in the Galilee is an institution offering enhanced education and care. 
  • CENTERS FOR ISRAEL
    •  
      • CLINICS – Giving back to the community.
      • OPTOMETRY CLINIC
      • LEGAL CLINIC
      • PSYCHOLOGY CLINIC
      • MUSIC DEPARTMENT
      • BESA
        BEGIN SADAT INITIATIVE
      • THE RUTH AND EMANUEL RACKMAN CENTER
        FOR THE ADVANCEMENT OF WOMEN’S STATUS
  • DONATE
  • Contact

Improved Cancer Treatment Advances Thanks to Prof. Nir's Research Work

May 2015

A “trio” of proteins that appear to play a pivotal role in the onset of various cancers has been revealed by Prof. Uri Nir, Director of the Nano Medicine Center at the Institute of Nanotechnology and Advanced Materials (BINA) and Dean of The Mina and Everard Goodman Faculty of Life Sciences at Bar-Ilan University. With this finding, Prof. Nir is now proceeding to develop novel anti-cancer drugs that will target key regulators.

Uri NirHe uses nanosized vehicles to deliver cancer-fighting drugs directly to malignant cells. Working together with Dr. Yoav Pass, Prof. Nir’s techniques may make it possible to achieve better results with lower doses, leading to a reduction in chemotherapy-related side effects. His lab studies the involvement of stress response circuits in the adaptation of cells to stress insults, and in the growth of cancer cells.

The Three “Cross-Talking” Proteins

Three intracellular proteins which “cross-talk” with each other are being studied in Nir’s lab.

The enzyme Fer resides in both the cytoplasm and nucleus of cells, which supports the resistance of cells to various stress cues such as oxidation and nutrient deprivation. Nir’s team has recently discovered a previously unknown form of Fer, which is solely expressed in malignant cells. Specific targeting of this form led to the programmed cell death of the treated cancer cells. Thus, this form of Fer is a novel target for cancer intervention. 

TRNP, a nuclear protein that associates with chromatin and is highly expressed in neuronal brain cells, is a transcription regulator that supports the survival of these cells under defined stress conditions. The malfunctioning of TRNP may, therefore, contribute to the onset of neuronal cell death and consequent neurodegenerative diseases. Nir’s lab is currently examining the functioning of TRNP in mice models under normal and pathological conditions.

TMF is a protein that Prof. Nir’s group recently characterized as a master regulator, which modulates the response of cells to stress insults and thus plays a key role in the acquired resistance of cancer cells to chemotherapeutic agents. They are now devising molecular approaches for manipulating the TMF system and, thereby, restoring the sensitivity of cancer cells to chemotherapeutic treatments.

Focusing on Fer’s Role in Cancer Progression 

Key scientific goals of Nir’s group include further exploration of the role of Fer in cancer and inflammatory diseases, and identification of low molecular weight compounds that would affect Fer and attenuate the progression of cancer and inflammatory diseases. 

In addition, they hope to identify and characterize substrates of the Fer enzyme and further elucidate its function. Lastly, they would like to investigate the tumor suppressive activity of TMF using modified TMF genes, for the purpose of developing novel anti-cancer gene therapy approaches.

To learn more about Prof. Nir’s research to combat cancer, call Howard Charish at 212-906-3900.

Palm trees in a lush garden with a modern tower in the background, showcasing a blend of nature and architecture.

1. WELCOME

An essential partner in Bar-Ilan University’s development, American Friends of Bar-Ilan University provides vital philanthropic support for one of the fastest growing institutions of higher education in Israel.

3. LOOK FOR

4. READ ABOUT

BIU News Topics
  • All News
  • AFBIU News
  • Archeology
  • Biomedical Research
  • BIU Happenings
  • Engineering
  • Geopolitics
  • Health
  • History
  • Innovation
  • Jewish Studies
  • Literature
  • Medical School
  • Nanotechnology
  • Profiles
  • Science
  • Torah Studies

5. GET INVOLVED

Vibrant red roses in a garden with the word "DONATE" prominently displayed, encouraging charitable contributions and support for a cause.

ABOUT US

  • HOME
  • Bar-Ilan University
  • American Friends of Bar-Ilan (AFBIU)
  • AFBIU Financial Information
  • Board of Directors
  • Contact us

BAR-ILAN HIGHLIGHTS

  • Science & Technology
  • Jewish Studies and Archaeology
  • Outreach: Centers for Israel
  • School of Medicine in the Galilee

GET INVOLVED

  • Scholarship Fund
  • Computer Science Building
  • Medical School
  • Faculty Recruitment
  • Planned Giving
  • IRA Giving
  • Israel Bonds

SEARCH

©2018 American Friends of Bar-Ilan University, all rights reserved | Privacy Policy